← Evidence map

ArticleMolecular cancer research : MCR2012

PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.

Alexandra Hockla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

41 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23258495